{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:03:54Z","timestamp":1790723034054,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0192497","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T13:31:32Z","timestamp":1520429492000},"page":"e0192497","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease"],"prefix":"10.1371","volume":"13","author":[{"given":"Lara","family":"Marrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sch\u00f6ndorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Catherine","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Deleidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Meixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Klink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glatza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Johannes","family":"Gloeckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7688-3124","authenticated-orcid":true,"given":"Jared","family":"Sterneckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8619(05)70259-0","article-title":"Epidemiology of Parkinson&apos;s disease","volume":"14","author":"CM Tanner","year":"1996","journal-title":"Neurol Clin"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrg3764","article-title":"Investigating human disease using stem cell models","volume":"15","author":"JL Sterneckert","year":"2014","journal-title":"Nat Rev Genet"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"e1002141","DOI":"10.1371\/journal.pgen.1002141","article-title":"Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson&apos;s disease","volume":"7","author":"CB Do","year":"2011","journal-title":"PLoS Genet"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1086\/429256","article-title":"Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations","volume":"76","author":"J Kachergus","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"A Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson&apos;s disease","volume":"44","author":"C Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-9-47","article-title":"The role of the LRRK2 gene in Parkinsonism","volume":"9","author":"JQ Li","year":"2014","journal-title":"Mol Neurodegener"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1468-1331.2007.01685.x","article-title":"A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson&apos;s disease in Russia","volume":"14","author":"SN Illarioshkin","year":"2007","journal-title":"Eur J Neurol"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/jnnp.2005.085019","article-title":"Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson&apos;s disease cohort","volume":"77","author":"CH Williams-Gray","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson&apos;s disease","volume":"41","author":"J Simon-Sanchez","year":"2009","journal-title":"Nat Genet"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"e70724","DOI":"10.1371\/journal.pone.0070724","article-title":"Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus","volume":"8","author":"D Trabzuni","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.stem.2013.01.008","article-title":"Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression","volume":"12","author":"P Reinhardt","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/emmm.201200215","article-title":"Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson&apos;s disease","volume":"4","author":"A Sanchez-Danes","year":"2012","journal-title":"EMBO Mol Med"},{"key":"ref14","article-title":"Progressive degeneration of human neural stem cells caused by pathogenic LRRK2","author":"GH Liu","year":"2012","journal-title":"Nature"},{"issue":"141","key":"ref15","doi-asserted-by":"crossref","first-page":"141ra90","DOI":"10.1126\/scitranslmed.3003985","article-title":"Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson&apos;s disease","volume":"4","author":"O Cooper","year":"2012","journal-title":"Sci Transl Med"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.stem.2016.08.002","article-title":"Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson&apos;s Disease","volume":"19","author":"CH Hsieh","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12031-012-9820-7","article-title":"Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants","volume":"48","author":"T Botta-Orfila","year":"2012","journal-title":"J Mol Neurosci"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.parkreldis.2008.10.008","article-title":"Genetic factors influencing age at onset in LRRK2-linked Parkinson disease","volume":"15","author":"Y Golub","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"32","key":"ref19","doi-asserted-by":"crossref","first-page":"19433","DOI":"10.1074\/jbc.M115.660001","article-title":"Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates alpha-Synuclein Gene-induced Neurodegeneration","volume":"290","author":"JP Daher","year":"2015","journal-title":"J Biol Chem"},{"issue":"28","key":"ref20","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","article-title":"G2019S-LRRK2 Expression Augments alpha-Synuclein Sequestration into Inclusions in Neurons","volume":"36","author":"LA Volpicelli-Daley","year":"2016","journal-title":"J Neurosci"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.scr.2016.09.019","article-title":"Generation of induced pluripotent stem cells derived from a 77-year-old healthy woman as control for age related diseases","volume":"17","author":"N Nimsanor","year":"2016","journal-title":"Stem Cell Res"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"K Okita","year":"2011","journal-title":"Nat Methods"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/mds.25469","article-title":"SNCA: major genetic modifier of age at onset of Parkinson&apos;s disease","volume":"28","author":"K Brockmann","year":"2013","journal-title":"Mov Disord"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson&apos;s disease","volume":"46","author":"MA Nalls","year":"2014","journal-title":"Nat Genet"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"e59252","DOI":"10.1371\/journal.pone.0059252","article-title":"Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling","volume":"8","author":"P Reinhardt","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.20808","article-title":"LRRK2 expression linked to dopamine-innervated areas","volume":"59","author":"D Galter","year":"2006","journal-title":"Ann Neurol"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"e63778","DOI":"10.1371\/journal.pone.0063778","article-title":"Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice","volume":"8","author":"F Giesert","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nchembio.538","article-title":"Characterization of a selective inhibitor of the Parkinson&apos;s disease kinase LRRK2","volume":"7","author":"X Deng","year":"2011","journal-title":"Nat Chem Biol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20100483","article-title":"14-3-3 binding to LRRK2 is disrupted by multiple Parkinson&apos;s disease-associated mutations and regulates cytoplasmic localization","volume":"430","author":"RJ Nichols","year":"2010","journal-title":"Biochem J"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1021\/pr9008578","article-title":"Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2","volume":"9","author":"CJ Gloeckner","year":"2010","journal-title":"J Proteome Res"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1021\/cb2002413","article-title":"Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson&apos;s disease-related toxicity in human neurons","volume":"6","author":"N Ramsden","year":"2011","journal-title":"ACS Chem Biol"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.stemcr.2015.11.004","article-title":"Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson&apos;s Disease-Related LRRK2 G2019S Mutation","volume":"5","author":"AJ Schwab","year":"2015","journal-title":"Stem Cell Reports"},{"issue":"Suppl 1","key":"ref33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson&apos;s disease","volume":"139","author":"A Bose","year":"2016","journal-title":"J Neurochem"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/hmg\/dds003","article-title":"LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1","volume":"21","author":"X Wang","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncb2012","article-title":"PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1","volume":"12","author":"S Geisler","year":"2010","journal-title":"Nat Cell Biol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1073\/pnas.0911187107","article-title":"PINK1-dependent recruitment of Parkin to mitochondria in mitophagy","volume":"107","author":"C Vives-Bauza","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1074\/jbc.M112.391680","article-title":"Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons","volume":"288","author":"A Rakovic","year":"2013","journal-title":"J Biol Chem"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","article-title":"Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy","volume":"20","author":"NC Chan","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"22","key":"ref39","doi-asserted-by":"crossref","first-page":"19630","DOI":"10.1074\/jbc.M110.209338","article-title":"Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane","volume":"286","author":"SR Yoshii","year":"2011","journal-title":"J Biol Chem"},{"key":"ref40","article-title":"The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK\/ERK pathway","author":"JM Bravo-San Pedro","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-016-0065-1","article-title":"Dysregulation of autophagy and mitochondrial function in Parkinson&apos;s disease","volume":"5","author":"B Wang","year":"2016","journal-title":"Transl Neurodegener"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20070209","article-title":"LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson&apos;s disease mutants affect kinase activity","volume":"405","author":"M Jaleel","year":"2007","journal-title":"Biochem J"},{"issue":"46","key":"ref43","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson&apos;s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"AB West","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"E Greggio","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"9440","key":"ref45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson&apos;s disease","volume":"364","author":"MC Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"9440","key":"ref46","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between alpha-synuclein gene duplication and familial Parkinson&apos;s disease","volume":"364","author":"P Ibanez","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2990.2008.00952.x","article-title":"Review: Familial Parkinson&apos;s disease\u2014genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease","volume":"34","author":"C Schiesling","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson&apos;s disease puzzle","volume":"16","author":"JA Obeso","year":"2010","journal-title":"Nat Med"},{"issue":"9","key":"ref49","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nmeth.3507","article-title":"Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells","volume":"12","author":"D Paull","year":"2015","journal-title":"Nat Methods"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/hmg\/dds431","article-title":"Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity","volume":"22","author":"C Yao","year":"2013","journal-title":"Hum Mol Genet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0192497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:36:12Z","timestamp":1540262172000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0192497"}},"subtitle":[],"editor":[{"given":"Elisa","family":"Greggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0192497","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]}}}